Fludarabine-exposure predicts disease control following CD19-specific CAR T cell (tisagenlecleucel); A report from pediatric real-world CAR Consortium Meeting Abstract
| Authors: | Curran, K. J.; Fabrizio, V. A.; Mauguen, A.; Boelens, J. J.; Baggott, C.; Prabhu, S.; Placenta, H.; Phillips, C. L.; Rossoff, J.; Stefanski, H.; Talano, J.; Moskop, A.; Margossian, S. P.; Verneris, M. R.; Myers, G.; Karras, N. A.; Brown, P. A.; Qayed, M.; Hermiston, M.; Satwani, P.; Krupski, C.; Keating, A.; Wilcox, R.; Rabik, C. A.; Chinnabhandar, V.; Kunicki, M.; Goksenin, A.; Mackall, C.; Laetsch, T. W.; Schultz, L. M. |
| Abstract Title: | Fludarabine-exposure predicts disease control following CD19-specific CAR T cell (tisagenlecleucel); A report from pediatric real-world CAR Consortium |
| Meeting Title: | 27th Annual Scientific Meeting of the International Society for Cell and Gene Therapy (ISCT) |
| Journal Title: | Cytotherapy |
| Volume: | 23 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2021 May 25-28 |
| Meeting Location: | New Orleans Virtual |
| ISSN: | 1465-3249 |
| Publisher: | Elsevier Science Ltd. |
| Date Published: | 2021-05-01 |
| Start Page: | S27 |
| End Page: | S29 |
| Language: | English |
| ACCESSION: | WOS:000650965900021 |
| PROVIDER: | wos |
| DOI: | 10.1016/S1465324921002899 |
| Notes: | Meeting Abstract: 21 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work